<DOC>
	<DOCNO>NCT02525198</DOCNO>
	<brief_summary>There dearth research take multi-compound approach dietary intervention , human , aim improve outcome measure cognition . Animal research particular point towards fatty acid flavonoid potentiate effect , possibly even synergistic . Thus , study product administer present trial comprise compound , view investigate potential effect cognition old adult mild cognitive impairment ( MCI ) subjective memory impairment ( SMI ) .</brief_summary>
	<brief_title>The Cognitive Ageing Nutrition Neurogenesis ( CANN ) Trial</brief_title>
	<detailed_description>240 participant , age 55 , recruit ( 120 Norwich , 120 Melbourne ; include MCI SCI participant ) . Participants ask take study food day 12 month , come clinical assessment unit 3 occasion , baseline , 3 month 12 month , complete cognitive task battery performance may investigate context intervention . Urine , blood faecal sample collect magnetic resonance imaging ( MRI ) applicable half population ( i.e 60 MCI 60 SCI , 30 Norwich Melbourne ) .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Memory Disorders</mesh_term>
	<criteria>Male female , age â‰¥ 55 year Mild cognitive impairment ( MCI ) subjective memory impairment ( SMI ) indication clinical dementia depression Willing able provide write informed consent . Understands willing able comply study procedure . Fluent write spoken English . In good general health include blood biochemical , haematological urinalysis within normal range screening ( judged clinical advisor ) Normal , correct normal vision hear Right hand , MRI Stable use prescribed medication least four week Diagnosis Alzheimer 's disease ( AD ) form dementia significant neurological disorder Parent sibling develop premature dementia &lt; 60y ( suggestive familial monogenic form cognitive decline ) Past history MRI evidence brain damage include significant trauma , stroke , learn difficulty serious neurological disorder , include loss consciousness &gt; 24 hour History alcohol drug dependency within last 2 year Other clinically diagnose psychiatric disorder likely affect cognitive measure ( judge clinical adviser ) Existing diagnose gastrointestinal disorder likely impact absorption flavonoid fatty acid ( judged clinical adviser ) Major cardiovascular event , e.g . myocardial infarction stroke , last 12 month Carotid stent severe stenosis Known allergy fish component intervention supplement Existing medical condition likely affect study measure ( judge clinical adviser ) Uncontrolled hypertension ( Systolic Blood Pressure ( SBP ) &gt; 140mmHg , Diastolic Blood Pressure ( DBP ) &gt; 90mmHg ) BMI &gt; 40kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Mild cognitive impairment</keyword>
	<keyword>Subjective memory impairment</keyword>
	<keyword>Dementia</keyword>
	<keyword>Flavonoids</keyword>
	<keyword>Fatty acid</keyword>
	<keyword>Cognition</keyword>
	<keyword>Gut microflora</keyword>
</DOC>